secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001193125-23-195360
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare Q2 2023 revenue $15.86B; EPS $4.29; raises 2023 guidance
-----------------------------------------------------------------------

- Revenue $15.861B, up 7% YoY; net income $1.193B, diluted EPS $4.29 (vs $3.90).
- Adjusted EBITDA $3.056B; same facility admissions +2.2%, equivalent admissions +3.7%.
- 2023 guidance raised: revenue $63.25-$64.75B, EPS $17.70-$18.90.
- Quarterly dividend $0.60/share, payable Sept 29 to holders of record Sept 15.
- Repurchased 3.3M shares for $915M in Q2; $2.825B remaining authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312523195360/0001193125-23-195360-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312523195360/d536904d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-195360

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer